Font Size:
a
A
A
Keyword [Antiplatelet therapy]
Result: 141 - 160 | Page: 8 of 10
141.
Analysis Of Clinic Features Of 60 Cryptogenic Stroke Patients With Positive Contrast-enhanced Transcranial Doppler (c-TCD)
142.
Application Value Of Thromboelastography And Prediction Model In First-month Hemorrhage Risk Of Ischemic Stroke Patients Treated With Double Antiplatelet Therapy
143.
Clinical Study On The Relationship Between Minor Stroke With Clopidogrel-aspirin Antiplatelet Therapy And Cerebral Microbleeds
144.
Thrombelastogram Combined With Platelet Aggregation Rate Test Was Used To Evaluate The Efficacy And Safety Of Antiplatelet Therapy In Patients With Coronary Slow Flow
145.
The Guiding Role Of PEAR1 Gene Detection In Double Antiplatelet Therapy
146.
A Comparative Study Of Safety And Clinical Efficacy Between Ticagrelor And Clopidogrel In The Treatment Of Acute Coronary Syndrome With Thrombocytopenia
147.
Correlation Between Clopidogrel Resistance And Platelet Parameters In Patients With Acute Coronary Syndrome
148.
Clinical Comparative Study Of Argatroban And Dual Antiplatelet Therapy In The Treatment Of Cerebral Watershed Infarction Beyond The Time Window Of Thrombolysis
149.
Safety Evaluation Of The Prognosis Of Patients With Prophylactic Anticoagulation Therapy For Left Ventricular Dysfunction After PCI For Acute Myocardial Infarction
150.
Research Progress On The Relationship Between Anti-helicobacter Therapy And Upper Gastrointestinal Bleeding In DAPT Patients After PCI
151.
Antiplatelet Therapy In Elderly ACS Patients With High Ischemic And Bleeding Risk After 12 Months DAPT Following New-Generation DES
152.
Analysis The Effect Of Gene And Platelet Testing Guide Dual Anti-upgrade Therapy After PCI In Patients With ACS
153.
Clinical Outcomes Of Coronary Endarterectomy And The Importance Of Antiplatelet Therapy In Patients With Diffuse And/or Severely Calcified Coronary Artery Disease
154.
The Effect Of Preoperative Antiplatelet Drugs On The Short-term Prognosis Of Endovascular Therapy In Patients With Emergent Large Vessel Occlusive Stroke
155.
Impact Of Time From Dapt To Primary PCI And Administration With Gpi On Myocardial Reperfusion In Patients With STEMI
156.
Efficacy And Safety Of Different Durations Of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention:A Meta-Analysis
157.
Efficacy And Safety Analysis Of Different DAPT Regimens For Patients With Rapid Metabolism Of CYP2C19 Genotype After PCI
158.
Follow-up Study Of Antiplatelet Drugs In Patients With Acute Coronary Syndrome
159.
Safety Evaluation Of One-year Dual-antiplatelet Therapy After PCI In Coronary Heart Disease With Cerebral Infarction Patients
160.
The Study Of Gene Detection In Antiplatelet Therapy In Patients With Ischemic Stroke
<<First
<Prev
Next>
Last>>
Jump to